We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.24B
AUM Growth
+$127M
Cap. Flow
-$22.4M
Cap. Flow %
-1%
Top 10 Hldgs %
23.56%
Holding
2,404
New
91
Increased
577
Reduced
648
Closed
51

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.38M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.16M
3
XOM icon
ExxonMobil
XOM
+$2.1M
4
MSFT icon
Microsoft
MSFT
+$1.73M
5
TWTR
Twitter, Inc.
TWTR
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 13.98%
3 Financials 12.55%
4 Consumer Discretionary 8.54%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AURA icon
2176
Aura Biosciences
AURA
$791M
$13.4K ﹤0.01%
1,280
SRTA
2177
Strata Critical Medical Inc
SRTA
$528M
$13.4K ﹤0.01%
3,754
FF icon
2178
Future Fuel
FF
$256M
$13.4K ﹤0.01%
+1,644
New +$12.4K
PCYO icon
2179
Pure Cycle
PCYO
$273M
$13.4K ﹤0.01%
1,274
PRME icon
2180
Prime Medicine
PRME
$573M
$13.3K ﹤0.01%
+718
New +$13K
TLYS icon
2181
Tilly's
TLYS
$123M
$13.3K ﹤0.01%
+1,474
New +$12.9K
GLRE icon
2182
Greenlight Captial
GLRE
$513M
$13.3K ﹤0.01%
1,630
ZIMV
2183
DELISTED
ZimVie
ZIMV
$13.3K ﹤0.01%
1,422
+44
+3% +$384
FOSL icon
2184
Fossil Group
FOSL
$330M
$13.2K ﹤0.01%
+3,072
New +$12.8K
DGICA icon
2185
Donegal Group Class A
DGICA
$695M
$13.2K ﹤0.01%
931
CBNK icon
2186
Capital Bancorp
CBNK
$614M
$13.2K ﹤0.01%
561
JYNT icon
2187
The Joint Corp
JYNT
$122M
$13.2K ﹤0.01%
943
IRMD icon
2188
iRadimed
IRMD
$1.12B
$13.2K ﹤0.01%
465
GWH icon
2189
ESS Tech
GWH
$19.4M
$13.2K ﹤0.01%
361
ALTO icon
2190
Alto Ingredients
ALTO
$329M
$13.2K ﹤0.01%
4,566
REI icon
2191
Ring Energy
REI
$347M
$13.1K ﹤0.01%
5,331
OCUL icon
2192
Ocular Therapeutix
OCUL
$2.23B
$13.1K ﹤0.01%
4,666
CLAR icon
2193
Clarus
CLAR
$144M
$13.1K ﹤0.01%
1,671
SB icon
2194
Safe Bulkers
SB
$780M
$13.1K ﹤0.01%
4,485
PKBK icon
2195
Parke Bancorp
PKBK
$415M
$13K ﹤0.01%
628
VLGEA icon
2196
Village Super Market
VLGEA
$635M
$13K ﹤0.01%
+558
New +$12.4K
UPLD icon
2197
Upland Software
UPLD
$17.9M
$13K ﹤0.01%
182
STOK icon
2198
Stoke Therapeutics
STOK
$2.1B
$12.9K ﹤0.01%
1,402
+77
+6% +$801
RIDE
2199
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$12.9K ﹤0.01%
756
WLDN icon
2200
Willdan Group
WLDN
$1.28B
$12.9K ﹤0.01%
721
+99
+16% +$1.52K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 Portfolio in Review

As of Q4 2022, Metropolitan Life Insurance Company (MetLife) held 2,404 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 filing shows 91 new, 577 increased, 648 reduced and 51 closed positions. Its largest new stake was Vanguard Total Bond Market: 419,639 shares worth $30.1M. The largest sale was Apple, an estimated $5.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2022 buy was Vanguard Total Bond Market: 419,639 shares worth $30.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $22.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2022 reduction was Apple, cutting an estimated $5.38M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.72M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $2.24B portfolio in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 91 new positions and closed 51 in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6% quarter-over-quarter to $2.24B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.